OM

Outset Medical, Inc. [OM] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

OM Stock Summary

Top 10 Correlated ETFs

OM


Top 10 Correlated Stocks

OM


In the News

11:59 28 Mar 2024 OM

Outset Medical, Inc. (OM) Q4 2023 Earnings Call Transcript

Outset Medical, Inc. (OM) Q4 2023 Earnings Call Transcript

11:05 28 Mar 2024 OM

Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?

Outset Medical, Inc. (OM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

08:30 28 Mar 2024 OM

Outset Medical to Report Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, February 21, 2024

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2023 after the close of trading on Wednesday, February 21, 2024. On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief F.

04:05 28 Mar 2024 OM

Outset Medical to Present at BofA Home Care Conference

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a virtual panel discussion at the BofA Securities Home Care Conference on Monday, December 4, 2023, at 12:00pm PT / 3:00pm ET. The panel discussion will include Leslie Trigg, Outset's Chair and Chief Executive Officer, Michael Aragon, MD.

11:43 28 Mar 2024 OM

5 Struggling Stocks to Buy at a Discount

These five companies have glimmers of hope that the market has yet to fully recognize. Each is trading at a significant discount to recent highs.

06:30 28 Mar 2024 OM

2 of the Cheapest Stocks I Own

Target has moved past its inventory woes and is showing positive signs. Outset Medical has faced setbacks, but still has a long runway for growth.

11:26 28 Mar 2024 OM

After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM)

Outset Medical, Inc. (OM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

11:19 28 Mar 2024 OM

Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM)

The heavy selling pressure might have exhausted for Outset Medical, Inc. (OM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

03:42 28 Mar 2024 OM

Outset Medical analysts slash price objective after multiple missteps

Outset Medical Inc stock was downgraded by BofA Securities analysts to ‘Underperform' from ‘Buy', and its price objective was cut to $3 per share from $32, after the medical technology company reported lower-than-expected preliminary third-quarter 2023 revenue and warned of reduced capital spending in 4Q.  "We think the Underperform rating is appropriate as Outset has had multiple execution missteps now and companies without profitability have even less margin of error given there is no real profitability valuation floor," the analysts wrote.

09:27 28 Mar 2024 OM

Outset Medical stock plunges on revenue hit from FDA warning letter

Outset Medical Inc shares sank as much as 40% in pre-market trading on Friday after the medical technology company reported lower-than-expected preliminary third-quarter 2023 revenue of $30.4 million and warned of reduced capital spending in 4Q.   Outset also said it now expects revenue for 2023 to be about $130 million, down from the company's previous forecast of $144 million to $150 million in August.

OM Financial details

Company Rating
Neutral
Market Cap
100.51M
Income
-172.8M
Revenue
130.38M
Book val./share
2.45
Cash/share
4.05
Dividend
-
Dividend %
-
Employees
480
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
-1.46
Forward P/E
-1.17
PEG
-4.11
P/S
1.96
P/B
1.69
P/C
0.57
P/FCF
-1.78
Quick Ratio
4.33
Current Ratio
5.35
Debt / Equity
1.11
LT Debt / Equity
1.1
-
-
EPS (TTM)
-3.5
EPS next Y
-1.98
EPS next Q
-0.54
EPS this Y
2.96%
EPS next Y
-43.43%
EPS next 5Y
-81.43%
EPS last 5Y
8.92%
Revenue last 5Y
53.95%
Revenue Q/Q
0.48%
EPS Q/Q
-17.2%
-
-
-
-
SMA20
-33.33%
SMA50
-50%
SMA100
-50%
Inst Own
79.1%
Inst Trans
0.73%
ROA
-57%
ROE
-88%
ROC
-0.68%
Gross Margin
20%
Oper. Margin
-131%
Profit Margin
-133%
Payout
-
Shs Outstand
50.51M
Shs Float
46.36M
-
-
-
-
Target Price
27
52W Range
1.975-24.13
52W High
-90.35%
52W Low
+131.5%
RSI
39
Rel Volume
0.07
Avg Volume
1.04M
Volume
76.14K
Perf Week
4.28%
Perf Month
-34.79%
Perf Quarter
-76.87%
Perf Half Y
-78.97%
-
-
-
-
Beta
2.037
-
-
Volatility
0.1%, 0.57%
Prev Close
5.23%
Price
2.315
Change
4.28%

OM Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.53.052.252.42.63
Net income per share
-2.27-7.38-2.89-3.38-3.48
Operating cash flow per share
-2.34-6.05-2.86-3.03-2.65
Free cash flow per share
-2.45-6.61-2.93-3.2-2.72
Cash per share
2.3319.257.455.974.1
Book value per share
-12.3720.098.215.112.48
Tangible book value per share
-12.3720.098.215.112.48
Share holders equity per share
-12.3720.098.215.112.48
Interest debt per share
1.112.50.872.223
Market cap
1.83B929.79M2.1B1.24B268.27M
Enterprise value
1.82B673.42M1.96B1.27B335.95M
P/E ratio
-26.73-7.7-15.93-7.63-1.55
Price to sales ratio
121.0618.6220.4810.782.06
POCF ratio
-25.97-9.39-16.13-8.53-2.04
PFCF ratio
-24.81-8.6-15.75-8.07-1.99
P/B Ratio
-4.92.835.625.062.18
PTB ratio
-4.92.835.625.062.18
EV to sales
120.5413.4919.0711.042.58
Enterprise value over EBITDA
-27.59-5.73-15.05-8.07-2.18
EV to operating cash flow
-25.86-6.8-15.02-8.74-2.56
EV to free cash flow
-24.7-6.23-14.67-8.27-2.49
Earnings yield
-0.04-0.13-0.06-0.13-0.64
Free cash flow yield
-0.04-0.12-0.06-0.12-0.5
Debt to equity
-0.080.120.10.421.11
Debt to assets
0.330.10.080.260.43
Net debt to EBITDA
0.122.181.11-0.19-0.44
Current ratio
3.29.437.937.195.26
Interest coverage
-16.52-49.67-76.1-45.15-13.39
Income quality
1.030.810.990.890.76
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.590.610.350.350.35
Research and developement to revenue
1.550.580.360.420.44
Intangibles to total assets
00000
Capex to operating cash flow
0.050.090.020.060.03
Capex to revenue
-0.22-0.18-0.03-0.07-0.03
Capex to depreciation
-1.7-2.88-0.6-1.61-0.59
Stock based compensation to revenue
0.060.430.170.240.3
Graham number
25.1457.7523.1219.7213.94
ROIC
0.2-0.31-0.31-0.45-0.64
Return on tangible assets
-0.77-0.3-0.28-0.41-0.55
Graham Net
-12.8115.516.343.741.25
Working capital
54.74M309.22M358.11M321.7M235.9M
Tangible asset value
-372.19M328.61M374.08M245.99M122.89M
Net current asset value
-380.91M270.69M320.42M219.52M100.3M
Invested capital
-0.080.120.10.421.11
Average receivables
2.5M5.19M16.03M26.84M30.53M
Average payables
4.17M4.95M3.36M1.18M3.22M
Average inventory
3.81M11.49M28.78M45.33M50.35M
Days sales outstanding
94.7547.2891.0788.892.33
Days payables outstanding
55.0628.686.772.2620.98
Days of inventory on hand
51.02106.56150.56192.62177.2
Receivables turnover
3.857.724.014.113.95
Payables turnover
6.6312.7353.88161.7617.4
Inventory turnover
7.153.432.421.892.06
ROE
0.18-0.37-0.35-0.66-1.41
Capex per share
-0.11-0.56-0.07-0.17-0.07

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.660.690.740.610.61
Net income per share
-0.86-0.9-0.9-0.93-0.77
Operating cash flow per share
-0.71-0.92-0.58-0.68-0.49
Free cash flow per share
-0.76-0.93-0.59-0.7-0.51
Cash per share
5.945.114.553.894.05
Book value per share
5.094.433.743.052.45
Tangible book value per share
5.094.433.743.052.45
Share holders equity per share
5.094.433.743.052.45
Interest debt per share
2.182.172.182.132.78
Market cap
1.25B897.61M1.07B543.05M271.87M
Enterprise value
1.28B964.28M1.14B609.99M339.55M
P/E ratio
-7.53-5.1-6.08-2.94-1.76
Price to sales ratio
39.0126.8229.717.898.91
POCF ratio
-36.19-20.06-37.99-15.97-11.12
PFCF ratio
-34.1-19.7-36.94-15.61-10.66
P/B Ratio
5.084.155.853.572.21
PTB ratio
5.084.155.853.572.21
EV to sales
39.9528.8131.5620.0911.13
Enterprise value over EBITDA
-33.72-23.61-27.87-14.23-10.1
EV to operating cash flow
-37.06-21.55-40.37-17.94-13.89
EV to free cash flow
-34.92-21.16-39.26-17.54-13.32
Earnings yield
-0.03-0.05-0.04-0.09-0.14
Free cash flow yield
-0.03-0.05-0.03-0.06-0.09
Debt to equity
0.420.480.560.681.11
Debt to assets
0.260.280.310.340.43
Net debt to EBITDA
-0.79-1.63-1.64-1.56-2.01
Current ratio
7.197.626.345.355.26
Interest coverage
-19-14.78-14.01-14.15-10.93
Income quality
0.8349.73K0.6436.56K0.63
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.310.350.310.390.34
Research and developement to revenue
0.360.410.410.530.41
Intangibles to total assets
00000
Capex to operating cash flow
0.060.020.030.020.04
Capex to revenue
-0.07-0.02-0.02-0.03-0.03
Capex to depreciation
-1.664.88-0.53-0.53-0.73
Stock based compensation to revenue
0.2300.2800.3
Graham number
9.99.488.77.966.5
ROIC
-0.11-0.13-0.15-0.17-0.14
Return on tangible assets
-0.1-0.12-0.13-0.15-0.12
Graham Net
3.733.122.481.791.23
Working capital
321.7M293.01M260.58M230.75M235.9M
Tangible asset value
245.99M216.29M183.11M152.06M122.89M
Net current asset value
219.52M190.9M158.07M128.29M100.3M
Invested capital
0.420.480.560.681.11
Average receivables
25.29M31.19M35.61M36.2M34.24M
Average payables
1.02M1.3M2.1M2.55M4.35M
Average inventory
53.37M49.6M46.11M46.38M48.74M
Days sales outstanding
78.9392.2892.15105.2197.3
Days payables outstanding
2.036.627.0411.1723.01
Days of inventory on hand
173.29158.88141.32187.16194.31
Receivables turnover
1.140.980.980.860.93
Payables turnover
44.3313.612.788.063.91
Inventory turnover
0.520.570.640.480.46
ROE
-0.17-0.2-0.24-0.3-0.31
Capex per share
-0.04-0.02-0.02-0.02-0.02

OM Frequently Asked Questions

What is Outset Medical, Inc. stock symbol ?

Outset Medical, Inc. is a US stock , located in San jose of Ca and trading under the symbol OM

Is Outset Medical, Inc. buy or a sell ?

4 stock analysts have 4 predictions with a medium analyst target price of $27.75. The lowest prediction is $23 and the highest is $34

What is OM stock prediction ?

What is Outset Medical, Inc. stock quote today ?

Outset Medical, Inc. stock price is $2.315 today.

Is Outset Medical, Inc. stock public?

Yes, Outset Medical, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap